✨ Your Portfolio is fetched and updated from zerodha.
Small Miscellaneous

Novartis India Ltd.

NOVARTIND

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹2,340 Cr.
P/E
22.77

Novartis India Ltd.

  • Novartis
  • Panacea Biotec
  • Indoco Remedies
  • TJI Pharma - Small Cap
FAQs on Novartis India Ltd. Shareprice

Novartis has given lower returns compared to its competitors.
Novartis has grown at ~2.8% over the last 7yrs while peers have grown at a median rate of 12.34%

Novartis is not expensive.
Latest PE of Novartis is 22.84, while 3 year average PE is 41.16.
Also latest EV/EBITDA of Novartis is 17.94 while 3yr average is 29.06.

View FAQ's On Business
Growth Table
  • Novartis India Ltd.
  • Panacea Biotec
  • Indoco Remedies
Balance Sheet
  • Novartis India Ltd.
  • Panacea Biotec
  • Indoco Remedies
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Novartis India Ltd.
  • Panacea Biotec
  • Indoco Remedies
Cash Flow
  • Novartis India Ltd.
  • Panacea Biotec
  • Indoco Remedies
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Novartis India Ltd.
  • Panacea Biotec
  • Indoco Remedies
Quarterly Results
  • Novartis India Ltd.
  • Panacea Biotec
  • Indoco Remedies
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Novartis India Ltd. Financials

Balance sheet of Novartis is moderately strong.

The debt of Novartis is decreasing.
Latest debt of Novartis is -₹1,296.06 Crs as of Mar-25.
This is less than Mar-24 when it was -₹1,192.14 Crs.

Yes, profit is increasing.
The profit of Novartis is ₹103 Crs for TTM, ₹101 Crs for Mar 2025 and ₹85.19 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Novartis latest dividend payout ratio is 61.15% and 3yr average dividend payout ratio is 82.33%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech